Literature DB >> 24500603

Birth outcomes of pregnancies fathered by men with multiple sclerosis.

E Lu1, F Zhu1, Y Zhao2, M van der Kop3, A D Sadovnick4, A Synnes5, L Dahlgren6, A Traboulsee1, H Tremlett7.   

Abstract

We linked several population-based clinical and health administrative databases in British Columbia, Canada. We identified and compared birth outcomes of pregnancies fathered by men with multiple sclerosis (MS) (n=202) and men from a frequency-matched general population cohort (n=981) between 1996 and 2010. Using multivariate models, we analyzed the association of paternal MS, disease duration at conception and disability (as measured by the Expanded Disability Status Scale) with birth weight and gestational age. Paternal MS and MS-related clinical factors were not significantly associated with birth outcomes (p>0.05). This study provides assurance to expecting fathers with MS and their families.
© The Author(s) 2014.

Entities:  

Keywords:  Multiple sclerosis; birth; father; men; pregnancy

Mesh:

Year:  2014        PMID: 24500603     DOI: 10.1177/1352458514521308

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  6 in total

Review 1.  Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.

Authors:  Maria Pia Amato; Emilio Portaccio
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

Review 2.  Management of women with multiple sclerosis through pregnancy and after childbirth.

Authors:  Patricia K Coyle
Journal:  Ther Adv Neurol Disord       Date:  2016-03-02       Impact factor: 6.570

3.  Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety.

Authors:  Gavin Giovannoni; Andrew Galazka; Regina Schick; Thomas Leist; Giancarlo Comi; Xavier Montalban; Doris Damian; Fernando Dangond; Stuart Cook
Journal:  Drug Saf       Date:  2020-07       Impact factor: 5.606

4.  Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations.

Authors:  Beatriz Canibaño; Dirk Deleu; Boulenouar Mesraoua; Gayane Melikyan; Faiza Ibrahim; Yolande Hanssens
Journal:  J Drug Assess       Date:  2020-01-23

Review 5.  Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies.

Authors:  Isabella Laura Simone; Carla Tortorella; Alma Ghirelli
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

6.  Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.

Authors:  Chiara Pecori; Marta Giannini; Emilio Portaccio; Angelo Ghezzi; Bahia Hakiki; Luisa Pastò; Lorenzo Razzolini; Andrea Sturchio; Laura De Giglio; Carlo Pozzilli; Damiano Paolicelli; Maria Trojano; Maria Giovanna Marrosu; Francesco Patti; Gian Luigi Mancardi; Claudio Solaro; Rocco Totaro; Maria Rosaria Tola; Giovanna De Luca; Alessandra Lugaresi; Lucia Moiola; Vittorio Martinelli; Giancarlo Comi; Maria Pia Amato
Journal:  BMC Neurol       Date:  2014-05-26       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.